Kura Oncology (KURA)
(Delayed Data from NSDQ)
$21.06 USD
+0.55 (2.68%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $21.09 +0.03 (0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.63 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | 6.35% |
ABR | 1.14 |
Earnings ESP
|
1.71% |
---|---|
Current Year | -2.45 |
Next Year | -2.60 |
EPS (TTM) | -2.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 18.93M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 42.20M |
Low Estimate | NA | NA | NA | 4.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.63 | -0.62 | -2.45 | -2.60 |
# of Estimates | 8 | 6 | 9 | 8 |
Most Recent Consensus | -0.62 | -0.62 | -2.45 | -2.65 |
High Estimate | -0.60 | -0.52 | -2.34 | -2.30 |
Low Estimate | -0.67 | -0.72 | -2.55 | -2.89 |
Year ago EPS | -0.50 | -0.55 | -2.08 | -2.45 |
Year over Year Growth Est. | -26.00% | -12.73% | -17.79% | -6.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 4 | 7 | 5 |
Up Last 60 Days | 3 | 4 | 7 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.63 | -0.62 | -2.45 | -2.60 |
7 Days Ago | -0.63 | -0.62 | -2.45 | -2.60 |
30 Days Ago | -0.66 | -0.68 | -2.56 | -2.67 |
60 Days Ago | -0.66 | -0.68 | -2.56 | -2.67 |
90 Days Ago | -0.66 | -0.68 | -2.56 | -2.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.62 | -0.62 | -2.45 | -2.64 |
Zacks Consensus Estimate | -0.63 | -0.62 | -2.45 | -2.60 |
Earnings ESP | 1.71% | -0.32% | 0.00% | -1.43% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.59 | -0.55 | -0.50 | NA |
Estimate | -0.63 | -0.56 | -0.56 | -0.56 | NA |
Difference | 0.04 | -0.03 | 0.01 | 0.06 | 0.02 |
Surprise | 6.35% | -5.36% | 1.79% | 10.71% | 3.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more